Skip to main content

Published locations for CVD-REAL 2: Lower mortality, CV risks with SGLT-2i vs. DPP-4i treatment in T2DM

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CVD-REAL 2: Lower mortality, CV risks with SGLT-2i vs. DPP-4i treatment in T2DM

User login

  • Reset your password
  • /content/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i-treatment-t2dm
  • /familypracticenews/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i
  • /internalmedicinenews/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i
  • /vascularspecialistonline/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp
  • /clinicalendocrinologynews/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp
  • /ecardiologynews/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i
  • /cardiology/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i-treatment
  • /endocrinology/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i
  • /internalmedicine/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i
  • /familymedicine/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i
  • /type-2-diabetes-icymi/article/170421/diabetes/cvd-real-2-lower-mortality-cv-risks-sglt-2i-vs-dpp-4i